<?xml version="1.0" encoding="ISO-8859-1"?>

<rss version="2.0">
  <channel>
    <title>The Options Insider</title>
    <link>http://www.theoptionsinsiders.com</link>
    <description>Featured Articles</description>
    <language>en-us</language>
    <copyright>Copyright 2010 The Options Insider</copyright>
	<lastBuildDate>Wed, 10 Mar 2010 14:16:00 GMT</lastBuildDate>
    <ttl>20</ttl>

<item>
<pubDate>Wed, 10 Mar 2010 14:10:00 GMT</pubDate>
<title>Midday Unusual Options Activity Update - HNT, C, AIG, ITMN, AMR, VLO</title>
<description>Implied volatility movers and unusual volume movers for midday 3/10 </description>
<link>http://www.theoptionsinsider.com/unusualactivity/?id=4064</link>
<guid>http://www.theoptionsinsider.com/unusualactivity/?id=4064</guid>
</item>

<item>
<pubDate>Wed, 10 Mar 2010 14:09:00 GMT</pubDate>
<title>Options Intelligence Report: SunTrust Banks, Inc. (STI)  and  Valero Energy Corp. (VLO)</title>
<description>SunTrust jumps but options contrarians express doubts. Featured tickers: STI  and  VLO </description>
<link>http://www.theoptionsinsider.com/unusualactivity/?id=4063</link>
<guid>http://www.theoptionsinsider.com/unusualactivity/?id=4063</guid>
</item>

<item>
<pubDate>Wed, 10 Mar 2010 12:04:00 GMT</pubDate>
<title>Options Intelligence Report: United Parcel Service, Inc. (UPS)  and  Regions Financial Corp. (RF)</title>
<description>Options Intelligence Report for United Parcel Service, Inc. (UPS) and Regions Financial Corp. (RF) </description>
<link>http://www.theoptionsinsider.com/unusualactivity/?id=4062</link>
<guid>http://www.theoptionsinsider.com/unusualactivity/?id=4062</guid>
</item>

<item>
<pubDate>Wed, 10 Mar 2010 09:54:00 GMT</pubDate>
<title>InterMune (ITMN) - FDA Panel Recommends Approval</title>
<description>ITMN options move as FDA and s Pulmonary-Allergy Drugs Advisory Committee (PADAC) recommends approval for the company and s New Drug Application (NDA) for pirfenidone. Pirfenidone is InterMune and s investigational drug candidate for the treatment of patients with idiopathic pulmonary fibrosis (IPF). </description>
<link>http://www.theoptionsinsider.com/unusualactivity/?id=4060</link>
<guid>http://www.theoptionsinsider.com/unusualactivity/?id=4060</guid>
</item>

<item>
<pubDate>Wed, 10 Mar 2010 09:28:00 GMT</pubDate>
<title>The Other Naked</title>
<description>An overview of naked calls </description>
<link>http://www.theoptionsinsider.com/education/?id=4059</link>
<guid>http://www.theoptionsinsider.com/education/?id=4059</guid>
</item>

<item>
<pubDate>Wed, 10 Mar 2010 08:42:00 GMT</pubDate>
<title>Morning Futures Roundup</title>
<description>A roundup of pre-session activity in the futures market - Will There be Some Surprises in the USDA March Crop Report This Year? </description>
<link>http://www.theoptionsinsider.com/unusualactivity/?id=4058</link>
<guid>http://www.theoptionsinsider.com/unusualactivity/?id=4058</guid>
</item>

<item>
<pubDate>Wed, 10 Mar 2010 08:06:00 GMT</pubDate>
<title>Broker Rundown: ShareBuilder</title>
<description>Coverage of online retail brokers continues with ShareBuilder. </description>
<link>http://www.theoptionsinsider.com/brokerage/?id=4057</link>
<guid>http://www.theoptionsinsider.com/brokerage/?id=4057</guid>
</item>

<item>
<pubDate>Wed, 10 Mar 2010 08:05:00 GMT</pubDate>
<title>Unusual Options Activity Review - QLGC, CMC, AIG, AMR, HD, GME, MHLD, HBAN, .MVR, XLP</title>
<description>Unusual options activity review for Tuesday, March 9, 2010 </description>
<link>http://www.theoptionsinsider.com/unusualactivity/?id=4056</link>
<guid>http://www.theoptionsinsider.com/unusualactivity/?id=4056</guid>
</item>

<item>
<pubDate>Tue, 9 Mar 2010 07:47:00 GMT</pubDate>
<title>Dividend Trade Strategies in the U.S. Options Industry, Part 3</title>
<description>Third installment of a series addressing looking at 2009 options industry growth. Although the U.S. equity options industry reported 3% growth in 2009, what many industry participants and observers do not realize is that this growth is solely attributable to an objectionable trading strategy called a &amp;#034;dividend trade.&amp;#034;
 </description>
<link>http://www.theoptionsinsider.com/industry/?id=4055</link>
<guid>http://www.theoptionsinsider.com/industry/?id=4055</guid>
</item>

<item>
<pubDate>Wed, 10 Mar 2010 23:50:00 GMT</pubDate>
<title>Risk Management Conference Report: View From The Buyside</title>
<description>Reporting from the CBOE Risk Management Conference </description>
<link>http://www.theoptionsinsider.com/industry/?id=4054</link>
<guid>http://www.theoptionsinsider.com/industry/?id=4054</guid>
</item>

</channel>
</rss>

